Dolby Laboratories, Inc. Insider Trading for February 2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Dolby Laboratories, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Dolby Laboratories, Inc. for February 2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26 2021 | DLB | Dolby Laboratories ... | Rollins Emily | Director | Grant | A | 0.00 | 2,462 | 0 | 2,462 | 0 to 2.5 K |
| Feb 24 2021 | DLB | Dolby Laboratories ... | Pendleton Todd | SVP, Chief Marketin ... | Option Exercise | M | 68.40 | 10,229 | 699,664 | 29,946 | |
| Feb 24 2021 | DLB | Dolby Laboratories ... | Pendleton Todd | SVP, Chief Marketin ... | Sell | S | 95.09 | 10,229 | 972,646 | 32,956 | 43.2 K to 33 K (-23.69 %) |
| Feb 24 2021 | DLB | Dolby Laboratories ... | Pendleton Todd | SVP, Chief Marketin ... | Buy | M | 68.40 | 10,229 | 699,664 | 43,185 | 33 K to 43.2 K (+31.04 %) |
| Feb 22 2021 | DLB | Dolby Laboratories ... | Pendleton Todd | SVP, Chief Marketin ... | Option Exercise | M | 68.40 | 2,100 | 143,640 | 40,175 | |
| Feb 22 2021 | DLB | Dolby Laboratories ... | Pendleton Todd | SVP, Chief Marketin ... | Option Exercise | M | 62.43 | 7,813 | 487,766 | 44,271 | |
| Feb 22 2021 | DLB | Dolby Laboratories ... | Pendleton Todd | SVP, Chief Marketin ... | Option Exercise | M | 64.60 | 2,250 | 145,350 | 16,500 | |
| Feb 22 2021 | DLB | Dolby Laboratories ... | Pendleton Todd | SVP, Chief Marketin ... | Sell | S | 94.13 | 2,306 | 217,055 | 32,956 | 35.3 K to 33 K (-6.54 %) |
| Feb 22 2021 | DLB | Dolby Laboratories ... | Pendleton Todd | SVP, Chief Marketin ... | Sell | S | 94.01 | 2,100 | 197,413 | 35,262 | 37.4 K to 35.3 K (-5.62 %) |
| Feb 22 2021 | DLB | Dolby Laboratories ... | Pendleton Todd | SVP, Chief Marketin ... | Buy | M | 68.40 | 2,100 | 143,640 | 37,362 | 35.3 K to 37.4 K (+5.96 %) |
| Feb 22 2021 | DLB | Dolby Laboratories ... | Pendleton Todd | SVP, Chief Marketin ... | Sell | S | 94.11 | 7,813 | 735,251 | 35,262 | 43.1 K to 35.3 K (-18.14 %) |
| Feb 22 2021 | DLB | Dolby Laboratories ... | Pendleton Todd | SVP, Chief Marketin ... | Buy | M | 62.43 | 7,813 | 487,766 | 43,075 | 35.3 K to 43.1 K (+22.16 %) |
| Feb 22 2021 | DLB | Dolby Laboratories ... | Pendleton Todd | SVP, Chief Marketin ... | Sell | S | 94.00 | 2,250 | 211,500 | 35,262 | 37.5 K to 35.3 K (-6.00 %) |
| Feb 22 2021 | DLB | Dolby Laboratories ... | Pendleton Todd | SVP, Chief Marketin ... | Buy | M | 64.60 | 2,250 | 145,350 | 37,512 | 35.3 K to 37.5 K (+6.38 %) |
| Feb 17 2021 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Option Exercise | M | 45.50 | 13,000 | 591,500 | 36,118 | |
| Feb 17 2021 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Sell | S | 95.00 | 13,000 | 1,235,000 | 50,010 | 63 K to 50 K (-20.63 %) |
| Feb 17 2021 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Buy | M | 45.50 | 13,000 | 591,500 | 63,010 | 50 K to 63 K (+25.99 %) |
| Feb 17 2021 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Option Exercise | M | 45.50 | 13,000 | 591,500 | 36,118 | |
| Feb 17 2021 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Sell | S | 95.00 | 13,000 | 1,235,000 | 50,010 | 63 K to 50 K (-20.63 %) |
| Feb 17 2021 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Buy | M | 45.50 | 13,000 | 591,500 | 63,010 | 50 K to 63 K (+25.99 %) |
| Feb 09 2021 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Option Exercise | M | 37.35 | 29,457 | 1,100,219 | 220,929 | |
| Feb 09 2021 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Sell | S | 91.86 | 5,357 | 492,107 | 32,895 | 38.3 K to 32.9 K (-14.00 %) |
| Feb 09 2021 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Sell | S | 91.95 | 29,457 | 2,708,483 | 38,252 | 67.7 K to 38.3 K (-43.51 %) |
| Feb 09 2021 | DLB | Dolby Laboratories ... | YEAMAN KEVIN J | President and CEO | Buy | M | 37.35 | 29,457 | 1,100,219 | 67,709 | 38.3 K to 67.7 K (+77.01 %) |
| Feb 08 2021 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Option Exercise | M | 45.50 | 23,118 | 1,051,869 | 0 | |
| Feb 08 2021 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Option Exercise | M | 45.50 | 2,882 | 131,131 | 49,118 | |
| Feb 08 2021 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Sell | S | 92.23 | 496 | 45,746 | 50,010 | 50.5 K to 50 K (-0.98 %) |
| Feb 08 2021 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Sell | S | 91.58 | 22,622 | 2,071,718 | 50,506 | 73.1 K to 50.5 K (-30.93 %) |
| Feb 08 2021 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Buy | M | 45.50 | 23,118 | 1,051,869 | 73,128 | 50 K to 73.1 K (+46.23 %) |
| Feb 08 2021 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Sell | S | 92.23 | 175 | 16,140 | 50,010 | 50.2 K to 50 K (-0.35 %) |
| Feb 08 2021 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Sell | S | 91.48 | 2,707 | 247,635 | 50,185 | 52.9 K to 50.2 K (-5.12 %) |
| Feb 08 2021 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Buy | M | 45.50 | 2,882 | 131,131 | 52,892 | 50 K to 52.9 K (+5.76 %) |
| Feb 08 2021 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Sell | S | 92.23 | 227 | 20,936 | 50,010 | 50.2 K to 50 K (-0.45 %) |
| Feb 08 2021 | DLB | Dolby Laboratories ... | SHERMAN MARK ANDREW | EVP, GEN. COUN. & S ... | Sell | S | 91.68 | 1,436 | 131,649 | 50,237 | 51.7 K to 50.2 K (-2.78 %) |
| Feb 04 2021 | DLB | Dolby Laboratories ... | TEVANIAN AVADIS | Director | Sell | S | 90.00 | 1,814 | 163,260 | 50,561 | 52.4 K to 50.6 K (-3.46 %) |
| Feb 04 2021 | DLB | Dolby Laboratories ... | TEVANIAN AVADIS | Director | Grant | A | 0.00 | 2,661 | 0 | 2,661 | 0 to 2.7 K |
| Feb 04 2021 | DLB | Dolby Laboratories ... | Sud Anjali | Director | Grant | A | 0.00 | 2,661 | 0 | 8,873 | 6.2 K to 8.9 K (+42.84 %) |
| Feb 04 2021 | DLB | Dolby Laboratories ... | SIBONI ROGER S | Director | Grant | A | 0.00 | 2,661 | 0 | 34,771 | 32.1 K to 34.8 K (+8.29 %) |
| Feb 04 2021 | DLB | Dolby Laboratories ... | Segars Simon | Director | Grant | A | 0.00 | 2,661 | 0 | 33,571 | 30.9 K to 33.6 K (+8.61 %) |
| Feb 04 2021 | DLB | Dolby Laboratories ... | Nicholson Ryan | VP, Corporate Contr ... | Sell | S | 91.01 | 2,237 | 203,583 | 10,223 | 12.5 K to 10.2 K (-17.95 %) |
| Feb 04 2021 | DLB | Dolby Laboratories ... | JASPER N WILLIAM JR | Director | Sell | S | 90.33 | 3,627 | 327,643 | 7,000 | 10.6 K to 7 K (-34.13 %) |
| Feb 04 2021 | DLB | Dolby Laboratories ... | GOTCHER PETER C | Director | Grant | A | 0.00 | 2,661 | 0 | 40,929 | 38.3 K to 40.9 K (+6.95 %) |
| Feb 04 2021 | DLB | Dolby Laboratories ... | Dolby David | Director | Grant | A | 0.00 | 2,661 | 0 | 76,639 | 74 K to 76.6 K (+3.60 %) |
| Feb 04 2021 | DLB | Dolby Laboratories ... | CHEW LEWIS | EVP & Chief Financi ... | Option Exercise | M | 42.98 | 30,000 | 1,289,400 | 60,918 | |
| Feb 04 2021 | DLB | Dolby Laboratories ... | CHEW LEWIS | EVP & Chief Financi ... | Sell | S | 90.82 | 30,000 | 2,724,669 | 105,598 | 135.6 K to 105.6 K (-22.12 %) |
| Feb 04 2021 | DLB | Dolby Laboratories ... | CHEW LEWIS | EVP & Chief Financi ... | Buy | M | 42.98 | 30,000 | 1,289,400 | 135,598 | 105.6 K to 135.6 K (+28.41 %) |
| Feb 04 2021 | DLB | Dolby Laboratories ... | Chau Micheline | Director | Grant | A | 0.00 | 2,661 | 0 | 60,803 | 58.1 K to 60.8 K (+4.58 %) |